🇺🇸 FDA
Patent

US 9789131

Compounds and methods for treating neurological and cardiovascular conditions

granted A61KA61K31/52A61K31/7076

Quick answer

US patent 9789131 (Compounds and methods for treating neurological and cardiovascular conditions) held by The Board of Regents of the University of Texas System expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/52, A61K31/7076, A61P, A61P25/00